Trials / Completed
CompletedNCT03769558
A Study of Juvenile Idiopathic Arthritis Patients Given Abatacept and the Number of Infections or Malignancies That Occur
Supplemental Data for the Juvenile Idiopathic Arthritis FDA Written Request
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 264 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 12 Months
- Healthy volunteers
- Not accepted
Summary
This study will determine the incidences of infections and malignancies among JIA patients treated with abatacept
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-Interventional | Non-Interventional |
Timeline
- Start date
- 2016-07-12
- Primary completion
- 2016-09-30
- Completion
- 2016-09-30
- First posted
- 2018-12-07
- Last updated
- 2020-03-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03769558. Inclusion in this directory is not an endorsement.